A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids

Ann Plast Surg. 2009 Dec;63(6):688-92. doi: 10.1097/SAP.0b013e3181978753.

Abstract

Hypertrophic scars and keloids are common problems after injury and cause functional and cosmetic deformities. A wide variety of treatments have been advocated for hypertrophic scars and keloids regression. Unfortunately, the reported efficacy has been variable. This article explores antimitotic drugs described in the literature such as steroid injection, 5-FU, mitomycin C, and bleomycin, which mainly target the fibroblasts in scar tissue, have been proposed as the effective modalities for scar treatment and scar prevention after surgery, but restricted due to possible side effects. The current accepted treatment for hypertrophic scar and keloid are combination therapy and the early treatment which could achieve better efficacy and less adverse effect.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Apoptosis / drug effects
  • Bleomycin / administration & dosage
  • Cicatrix, Hypertrophic
  • Colchicine / administration & dosage
  • Colchicine / therapeutic use
  • Drug Therapy, Combination
  • Fibroblasts / drug effects
  • Fluorouracil / therapeutic use
  • Glucocorticoids / administration & dosage
  • Humans
  • Injections, Intralesional
  • Keloid
  • Mitomycin / administration & dosage
  • Mitomycin / therapeutic use
  • Mitosis Modulators / administration & dosage
  • Mitosis Modulators / therapeutic use*
  • Treatment Outcome
  • Tretinoin / administration & dosage
  • Tretinoin / therapeutic use
  • Triamcinolone / administration & dosage

Substances

  • Antimetabolites, Antineoplastic
  • Glucocorticoids
  • Mitosis Modulators
  • Bleomycin
  • Triamcinolone
  • Mitomycin
  • Tretinoin
  • Colchicine
  • Fluorouracil